Sunday Reading List: 3 Studies That Changed How I Think About Peptides

Most peptide content online is someone repeating what someone else said on a podcast. Very few people actually read the research. I want to change that here.

These are three studies I keep coming back to. Not because they are the flashiest. Because they fundamentally shifted how I approach peptide protocols. If you read nothing else this month, read these.

Study 1: BPC-157 Systematic Review (2025, American Journal of Sports Medicine)

This is the most comprehensive review of BPC-157 ever published. Researchers screened 544 articles and included 36 studies spanning from 1993 to 2024. The findings confirmed that BPC-157 enhances growth hormone receptor expression, promotes angiogenesis, and reduces inflammatory cytokines across muscle, tendon, ligament, and bone injury models.

Why it changed my thinking: Two things stood out. First, in the one human study included, 7 of 12 patients with chronic knee pain reported relief lasting over 6 months from a single intra-articular injection. That is a meaningful clinical signal from one injection. Second, the safety data across preclinical studies found no toxic or lethal dose across a massive dose range (6 mcg/kg to 20 mg/kg). No adverse effects in liver, spleen, lung, kidney, brain, thymus, prostate, or ovaries. The compound has a wider safety margin than most people realize.

The limitation that keeps me honest: there are still fewer than 30 total human subjects studied across all published BPC-157 trials. We need larger clinical trials. But the preclinical foundation is stronger than almost any other research peptide.

Study 2: MOTS-c as Exercise Mimetic (2015, Cell Metabolism + 2020 follow-up)

MOTS-c is a 16-amino acid peptide encoded by mitochondrial DNA. The original 2015 Cell Metabolism paper showed it promotes metabolic homeostasis, reduces obesity, and reverses insulin resistance in mice through AMPK activation, the same pathway triggered by exercise.

The follow-up work measured what happens in humans during exercise. Skeletal muscle MOTS-c levels increased 11.9-fold during acute exercise. Circulating levels increased 1.6-fold during exercise and remained elevated for hours afterward. Your body naturally produces more MOTS-c when you work out. Supplementing it externally gives your mitochondria that same signal on rest days.

Why it changed my thinking: This study is the reason MOTS-c is in my top 5. It reframed how I think about mitochondrial peptides. MOTS-c is not forcing something unnatural. It is amplifying a signal your body already uses. It also showed that MOTS-c had no effect on metabolically healthy mice, only on those with dysfunction. That means it is corrective, not performance-enhancing in the traditional sense. It fixes what is broken rather than pushing past normal limits.

Study 3: Lee and Burgess IV BPC-157 Safety Pilot (2025)

This one flew under the radar but it matters. Two healthy adults received intravenous BPC-157 infusions at doses up to 20 mg. That is orders of magnitude higher than typical subcutaneous protocols. The result: zero adverse events. No clinically meaningful changes in cardiac, hepatic, renal, thyroid, or metabolic biomarkers. Plasma concentrations returned to baseline within 24 hours.

Why it changed my thinking: This is the first published evidence of systemic IV BPC-157 administration in humans. The fact that a dose far exceeding normal protocols produced no measurable harm in any organ system is significant. It does not prove long-term safety. Two subjects is not a clinical trial. But it moved the needle from "we have no human safety data" to "the first human safety data looks clean." For a compound the FDA classified as having safety concerns, this study matters.

What I Take From All Three

The research base for peptides is not where most people think it is. It is not zero. It is not definitive. It is somewhere in between, with a handful of compounds building real evidence while most others run on anecdote and animal data alone. BPC-157 and MOTS-c are two of the few peptides where the research is actually accumulating in a meaningful direction.

Read the research yourself. Do not take my word for it or anyone else's. The links are publicly available through PubMed. The more informed you are, the better decisions you make about what goes into your body.

What study has changed how you think about a specific peptide? Drop it below. I want to read what you are reading.

Trusted Sources

Disclaimer: This content is for educational and research purposes only. Peptides are not approved for human use. Nothing here is medical advice. Consult a qualified professional for personalized guidance.